American Funds®



All Holdings

No holdings data is available at this time.
185 Total Holdings:
As of 9/30/15 (updated quarterly, upon availability).
All Holdings: 1 - 15 of 185
Asset Type
AXA SA Equity 11,284,200 $273,948,337.00 2.74%
Taiwan Semiconductor Manufacturing Co., Ltd. Equity 57,765,506 $230,513,570.00 2.31%
Novartis AG Equity 2,332,000 $214,811,591.00 2.15%
EDP - Energias de Portugal, SA Equity 56,327,000 $206,470,828.00 2.07%
Power Assets Holdings Ltd. Equity 17,877,500 $169,539,397.00 1.7%
British American Tobacco PLC Equity 3,005,300 $166,092,878.00 1.66%
Sun Hung Kai Properties Ltd. Equity 11,920,069 $155,367,116.00 1.56%
Nintendo Co., Ltd. Equity 902,400 $152,453,053.00 1.53%
International Consolidated Airlines Group, SA (CDI) Equity 15,770,000 $140,735,458.00 1.41%
Banco Santander, SA Equity 25,347,172 $134,965,796.00 1.35%
Wolseley PLC Equity 2,234,684 $130,727,403.00 1.31%
Enbridge Inc. Equity 3,518,560 $130,644,172.00 1.31%
AstraZeneca PLC Equity 2,045,000 $129,782,597.00 1.3%
Sumitomo Mitsui Financial Group, Inc. Equity 3,320,000 $126,384,073.00 1.27%
Ryohin Keikaku Co., Ltd. Equity 575,800 $117,887,586.00 1.18%
All Holdings: 1 - 15 of 185

Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.

Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses, which can be obtained from a financial professional and should be read carefully before investing.

Investing outside the United States involves risks, such as currency fluctuations, periods of illiquidity and price volatility, as more fully described in the prospectus. These risks may be heightened in connection with investments in developing countries.

  1. Excludes certain securities in initial period of acquisition.

For more information about the risks associated with each fund, go to its detailed fund information page or read the prospectus.